MétaCan
Menu
Back to cohort
Record W4413406537 · doi:10.1016/j.gore.2025.101933

Clinical outcomes of neuroendocrine carcinoma of the cervix: Retrospective review from a large academic cancer centre

2025· review· en· W4413406537 on OpenAlexaff
Jason Fernandes, Anjelica Hodgson, Kathy Han, Michael Milosevic, Jelena Luković, Stéphanie Lheureux, Sarah E. Ferguson, Anna Santiago, Jennifer Croke

Bibliographic record

VenueGynecologic Oncology Reports · 2025
Typereview
Languageen
FieldMedicine
TopicNeuroendocrine Tumor Research Advances
Canadian institutionsPrincess Margaret Cancer CentreUniversity of TorontoUniversity Health Network
Fundersnot available
KeywordsMedicineNeuroendocrine carcinomaCervixRetrospective cohort studyOncologyInternal medicineCancerCervical cancerCarcinomaGeneral surgery

Abstract

fetched live from OpenAlex

Objective: Neuroendocrine cervical carcinomas are a rare but aggressive malignancy associated with a poor prognosis and there is limited evidence to guide clinical decision-making. Our objective was to evaluate the patterns of practice and clinical outcomes of patients diagnosed with neuroendocrine cervical carcinoma. Methods: This was a retrospective chart review of patients diagnosed with neuroendocrine cervical carcinoma between 2007 and 2023. Demographic, treatment, and outcome data were extracted from the medical records and summarized using descriptive statistics. Results: In total 32 patients were identified. Median follow-up was 14.5 months, and median age at diagnosis was 52 (range 21-89), 31.3 % (10/32) were stage IVB at time of diagnosis. Primary treatment consisted of surgery in 10 patients (31.3 %) and chemo-radiation in 15 patients (46.9 %), with the remainder of patients (7/32, 21.9 %) receiving upfront palliative therapy. Adjuvant chemotherapy typically consisted of a combination of cisplatin and etoposide. Median OS for the full cohort was 19 months (2-year OS 39 %, 2-year LR 9 %, 2-year LRR 9 %). Primary surgery was generally offered to patients with earlier stage disease (IA2-IIA1) relative to primary chemoradiotherapy (IB1-IVB). Patients treated with primary surgery had significantly higher median OS compared to those treated with primary chemoradiotherapy (39 vs 19 months, p = 0.04). Treatment failure usually consistent of distant metastatic relapse (15/20, 75 %). Conclusion: In our single institution review of neuroendocrine carcinoma of the cervix, primary surgery was associated with improved OS; however, our sample size was small with a bias to offering upfront surgery to patients with earlier stage disease.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.009
Threshold uncertainty score0.018

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0030.007
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.066
GPT teacher head0.472
Teacher spread0.407 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueGynecologic Oncology ReportsSame topicNeuroendocrine Tumor Research AdvancesFrench-language works237,207